NCT00712478View on ClinicalTrials.gov

Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

114

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

Trial Locations (1)

92936

Paris La Défense

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY